20 February, 2024

The Aragonese vaccine against tuberculosis could reach the market in 2027 or 2028

Designed by the University of Zaragoza, with the professor of Microbiology and researcher at the IIS Aragón Carlos Martín at the helm, and developed by the Galician biopharmaceutical company Biofabri.
19 February, 2024

The IIS Aragón puts out to tender the Research Unit in Advanced Therapies of Aragón

These therapies are not yet carried out in Aragon and the Department of Health, through the IIS Aragón, has launched a project to implement them in our Community.
13 February, 2024

Organ-on-chip technology validated to evaluate the effect of a drug against glioblastoma

The Calcium Cellular Signaling research group of the IRB Lleida and the University of Lleida, in collaboration with the Aragón Health Research Institute and the University of Zaragoza, have established this technology that allows evaluating the efficacy of drugs in biological models.
13 February, 2024

Cristina Íñiguez: «The same wrinkles that we have on our face appear inside our brain»

Interview in Heraldo de Aragón with the head of the Neurology Service of the Hospital Clínico de Zaragoza, and researcher at the IIS Aragón, who has just been re-elected vice president of the board of directors of the Spanish Society of Neurology.